崩的蓝图:精确的生物标志物,分子级联和快速进展的ALS的工程衰退
Matei Șerban1,2,3, Corneliu Toader2,3, Răzvan-Adrian Covache-Busuioc1,2,3
1Puls Med Association, 051885 Bucharest, Romania.
International journal of molecular sciences
|August 28, 2025
概括
这一审查巩固了肌缩侧面硬化症 (ALS) 生物标志物发现的进展,整合了精确医学的分子,成像和数字工具. 生物标志物小组旨在早期诊断和实时监测ALS的疾病.
科学领域:
- 神经科学
- 生物标志物发现
- 精准医学
背景情况:
- 肌缩性侧面硬化 (ALS) 是一种异质的神经退行性疾病,缺乏足够的生物标志物来显示病变的进展和分子多样性.
- 目前的诊断和监测方法与ALS的快速进展和生物复杂性作斗争.
研究的目的:
- 通过分子,成像,遗传和数字领域对ALS生物标志物发现的最新进展进行审查和巩固.
- 提出一个框架,将多种生物标志物整合到精准医学方法中.
- 突出与快速进展的ALS表型相关的生物标志物和工具.
主要方法:
- 关于ALS生物标志物研究的现有文献.
- 新兴生物标志物的分析,如神经丝轻链 (NfL),pNfH,TDP-43和线粒体标志物.
- 探索先进的工具,包括单细胞转录学,脑脊液外体分析,MRI和可穿戴传感器.
主要成果:
- 一些生物标志物 (NfL,pNfH,TDP-43等) 提高对ALS病理生理学和动态的理解.
- 快速进展的ALS的特定分子特征 (例如SOD1 A5V,C9orf72) 正与可测量的生物标志物联系在一起.
- 开发工具提供了对疾病进展和发病的高分辨率洞察力.
结论:
- 整合多种生物标志物组可以实现早期的ALS诊断,实时监测和适应性临床试验设计.
- 这些进展有助于转向主动的,有生物学依据的临床治疗.
- 分子分析,数字表型和系统理解的融合有可能重新定义ALS管理.
更多相关视频
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.9K
07:14Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
6.1K
相关概念视频
01:26Cross-bridge Cycle
118.2K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.2K
03:03Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666